Gurusimha Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-05-2024
- Paid Up Capital ₹ 0.20 M
as on 18-05-2024
- Company Age 2 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
About Gurusimha Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Gurusimha Life Sciences Private Limited India is Malladi Sharma as CEO. Subrahmanyam Geddam and Haritha Malladi serve as directors at the Company.
- CIN/LLPIN
U33127AP2022PTC121027
- Company No.
121027
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Mar 2022
- Date of AGM
04 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gurusimha Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Malladi Sharma | CEO | 18-Mar-2022 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subrahmanyam Geddam  | Director | 06-Aug-2022 | Current |
| Haritha Malladi | Director | Current |
Financial Performance of Gurusimha Life Sciences.
Enhance accessibility to Gurusimha Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Gurusimha Life Sciences?
Unlock access to Gurusimha Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Q2rcm Healthcare Solutions Private LimitedActive 6 years 8 months
Subrahmanyam Geddam is a mutual person
- Trihaya Mediconsults Healthcare And Research Private LimitedActive 9 months 7 days
Subrahmanyam Geddam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gurusimha Life Sciences?
Gurusimha Life Sciences has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gurusimha Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gurusimha Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
